Our Executive Team

Dr. Peter Skarsgard, MD
President, Co-Founder
Dr. Skarsgard is a Cardiovascular Surgeon and Clinical Associate Professor of Surgery at the University of British Columbia, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. His area of expertise is mitral valve repair and complex valvular surgery. Based upon a simple clinical observation, Dr. Skarsgard developed and patented concepts for devices aimed toward percutaneous treatment of mitral regurgitation, utilizing proven surgical principles. These ideas form the basis for Calla and Orion.
Vincent Ledoux, MSc
Chief Operating Officer, Co-Founder
Mr. Ledoux is a Business and Strategy Specialist with a background in Corporations and Investment Banking worldwide. Since 2009, he has been deeply involved in startups - launching, advising and mentoring engineering and technology ventures. Vincent holds a Bachelor of Science in Economics and a Master of Science in Business Management from EMLyon Business School in France. While bringing valuable corporate and business inputs, Vincent will manage the day-to-day activities and coordinate the R&D.  
Dr. Jacqueline Saw, MD
Chief Medical Officer
Dr. Saw is a Clinical Professor of Medicine at the University of British Columbia, and a Structural Interventional Cardiologist at the Vancouver General Hospital. She is a recognized expert and key opinion leader in percutaneous device delivery, left atrial appendage occlusion, and spontaneous coronary artery dissection. Her contributions in CT imaging, pre-procedural planning, device selection, and device delivery have enabled acceleration of evolving structural interventions. She has considerable clinical trial experience, and has been a driving force for understanding women's health in cardiovascular disease. Dr. Saw will lead the pre-procedure planning and device delivery effort, and bring important clinical trial design input to Vesalius Cardiovascular.
Colin Nyuli, BASc
Director of Engineering
Mr. Nyuli is a biomedical engineer with more than a decade of experience in cardiovascular devices. He is a mitral valve specialist, with specific expertise in the design and development of mitral valve devices and complex percutaneous delivery systems. He has walked the path from concept to clinical trials. A graduate of the University of British Columbia School of Applied Science, Mr. Nyuli is also an intellectual property expert, with detailed experience in the creation and interpretation of intellectual property, and is a named inventor on more than 30 medical device patents. Mr. Nyuli leads the engineering team, and oversees the Vesalius quality management system.

Our Advisory Team

Dr. Donald Ricci, MD
Clinical and Strategic Advisory
Dr. Ricci is the CEO and co-founder of Evasc. Don trained in cardiology at Stanford University and the University of California, San Diego, and has a 35-year history of experience in coronary intervention and structural heart disease. He was director of the Cardiovascular Medicine program at Vancouver Hospital and is a Clinical Professor of Medicine at the University of British Columbia. He is a co-inventor of a number of medical devices, is named inventor on numerous device patents, and has broad experience in licensing technology to major strategic partners in the vascular field. Don brings important clinical and strategic inputs to Vesalius. 
Dr. Christopher Durkin, MD
Echocardiography Advisory
Dr. Durkin is a Clinical Assistant Professor of Anaesthesiology at the University of British Columbia, and a member of the Section of Cardiovascular Anaesthesiology at Vancouver General Hospital.  In addition to expertise in cardiovascular physiology and pharmacology, he holds National Board of Echocardiography Certification in Advanced Perioperative Transesophageal Echocardiography, and is an expert in 3D echo for intracardiac structural disease and procedures. Dr. Durkin brings critical inputs in 3D echo imaging, both procedurally and in planning, to Vesalius Cardiovascular.

Vesalius Cardiovascular Inc., 2016